Concourse Financial Group Securities, Inc. Amicus Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$9.55 - $12.09 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	BUY	$9.04 - $11.75 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$11.43 - $14.24 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$9.97 - $14.52 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$11.78 - $13.86 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$11.78 - $13.86 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$9.89 - $12.7 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$9.82 - $12.75 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$6.23 - $11.12 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$7.89 - $12.48 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$9.82 - $12.44 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$8.74 - $11.84 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $1,011 - $2,624	-110 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$13.47 - $24.89 $1,481 - $2,737	110 New	110 $3,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$6.63 - $11.16 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $0 - $0	0 New	0 $0

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$278 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$271 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$235 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$231 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$224 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account